Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Continuous expression of all four factors in normal mice, however, often induces teratomas17–19 or is fatal within days16, ostensibly due to tissue dysplasia18.”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [18]
In the citing paper
“Teratoma formation has been observed in partially reprogrammed animals, particularly when c-Myc is used in the partial rejuvenation cocktail (Abad et al., 2013; Ocampo et al., 2016; Ohnishi et al., 2014; Senís et al., 2018)”
From Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice (2024) · cites this paper as Abad et al., 2013
In the citing paper
“cellular reprogramming to pluripotency, although associated with tumor development (e.g., teratoma formation), can be achieved in vivo in mice by the forced expression of the Yamanaka factors”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“Although previous studies have indicated that expression of the Yamanaka factors in vivo can lead to cancer development or teratoma formation (Abad et al., 2013;Ohnishi et al., 2014), here, we demonstrate that tumor formation can be avoided by short-term induction of OSKM.”
From In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. (2016) · cites this paper as Abad et al., 2013
In the citing paper
“The Yamanaka factors possess oncogenic properties, which can lead to teratoma formation when persistently overexpressed in vivo (Abad et al., 2013; Ohnishi et al., 2014).”
From Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (2022) · cites this paper as Abad et al., 2013
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
In vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Embryonic stem cell potency fluctuates with endogenous retrovirus activity
Macfarlan, T. S., Gifford, W. D., Driscoll, S., Lettieri, K., Rowe, H. M., Bonanomi, D., Firth, A., Singer, O., Trono, D., & Pfaff, S. L. (2012) · Nature · doi:10.1038/nature11244 · Cited by 981
Hanna, J., Cheng, A. W., Saha, K., Kim, J., Lengner, C. J., Soldner, F., Cassady, J. P., Muffat, J., Carey, B. W., & Jaenisch, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004584107 · Cited by 847
Cited by
Items 101–200 of 617
Epigenetic predictors of species maximum life span and other life-history traits in mammals
Li, C. Z., Haghani, A., Robeck, T. R., Villar, D., Lu, A. T., Zhang, J., Faulkes, C. G., Vu, H., Ablaeva, J., Adams, D. M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adm7273 · Cited by 64
Teratoma: from spontaneous tumors to the pluripotency/malignancy assay
Bulić‐Jakuš, F., Bojanac, A. K., Jurić‐Lekić, G., Vlahović, M., & Sinčić, N. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.219 · Cited by 64
Regeneration, rejuvenation, and replacement: turning back the clock on tissue aging
Rando, T. A., & Jones, D. L. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040907 · Cited by 63
Ageing as a software design flaw
de Magalhães, J. P. (2023) · Genome Biology · doi:10.1186/s13059-023-02888-y · Cited by 63
Current Trends in Anti-Aging Strategies
Rosen, R. S., & Yarmush, M. L. (2023) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-120122-123054 · Cited by 63
In vivo reprogramming leads to premature death linked to hepatic and intestinal failure
Parras, A., Vílchez-Acosta, A., Desdín-Micó, G., Picó, S., Mrabti, C., Montenegro-Borbolla, E., Maroun, C. Y., Haghani, A., Brooke, R. T., Maza, M. D. C. L., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00528-5 · Cited by 62
Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming
Fang, J., Hsueh, Y., Soto, J., Sun, W., Wang, J., Gu, Z., Khademhosseini, A., & Li, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b04837 · Cited by 63
de Jesus, B. B., Marinho, S. P., Barros, S. A., Sousa‐Franco, A., Alves‐Vale, C., Carvalho, T., & Carmo‐Fonseca, M. (2018) · Nature Communications · doi:10.1038/s41467-017-01921-6 · Cited by 61
Cellular trajectories and molecular mechanisms of iPSC reprogramming
Apostolou, E., & Stadtfeld, M. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.06.002 · Cited by 61
Vitamin B12 is a limiting factor for induced cellular plasticity and tissue repair
Kovatcheva, M., Melendez, E., Chondronasiou, D., Pietrocola, F., Bernad, R., Caballe, A., Junza, A., Capellades, J., Holguín-Horcajo, A., Prats, N., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00916-6 · Cited by 58
Self-citationCellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
Huyghe, A., Trajkova, A., & Lavial, F. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.07.013 · Cited by 56
Epigenetic rejuvenation by partial reprogramming
Puri, D., & Wagner, W. (2023) · BioEssays · doi:10.1002/bies.202200208 · Cited by 57
Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells
Lee, S. H., Reed-Newman, T. C., Anant, S., & Ramasamy, T. S. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10031-8 · Cited by 56
Rejuvenation by cell reprogramming: a new horizon in gerontology
Goya, R. G., Lehmann, M., Chiavellini, P., Canatelli-Mallat, M., Hereñú, C. B., & Brown, O. A. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1075-y · Cited by 56
Salmikangas, P., Menezes‐Ferreira, M., Reischl, I. G., Tsiftsoglou, A. S., Kyselovič, J., Borg, J. J., Ruiz, S., Flory, E., Trouvin, J., Celis, P., et al. (2015) · Regenerative Medicine · doi:10.2217/rme.14.65 · Cited by 58
Linking Pluripotency Reprogramming and Cancer
Iglesias, J. M., Gumuzio, J., & Martín, Á. G. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0225 · Cited by 55
Cellular Reprogramming as a Therapeutic Target in Cancer
Xiong, S., Ye, F., & Cheng, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.05.001 · Cited by 54
Mukherjee, S., Yadav, G., & Kumar, R. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i6.521 · Cited by 54
Emerging rejuvenation strategies—Reducing the biological age
Zhang, B., Trapp, A., Kerepesi, C., & Gladyshev, V. N. (2022) · Aging Cell · doi:10.1111/acel.13538 · Cited by 51
Reversibility of irreversible aging
Galkin, F., Zhang, B., Dmitriev, S. E., & Gladyshev, V. N. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.008 · Cited by 51
Toward a Unified Theory of Aging and Regeneration
West, M. D., Sternberg, H., Labat, I., Janus, J., Chapman, K. B., Malik, N. N., de Grey, A. D. N. J., & Larocca, D. (2019) · Regenerative Medicine · doi:10.2217/rme-2019-0062 · Cited by 51
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
(2025) · doi:10.1038/s44321-025-00265-9 · Cited by 49
Chemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
(2022) · doi:10.1101/2022.08.29.505222 · Cited by 49
iPSCs: On the Road to Reprogramming Aging
Soria-Valles, C., & López-Otín, C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.010 · Cited by 48
Age reprogramming: cell rejuvenation by partial reprogramming
Singh, P. B., & Zhakupova, A. (2022) · Development · doi:10.1242/dev.200755 · Cited by 47
Taguchi, J., Shibata, H., Kabata, M., Kato, M., Fukuda, K., Tanaka, A., Ohta, S., Ukai, T., Mitsunaga, K., Yamada, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25249-4 · Cited by 46
The promise and challenges of cell therapy for psoriasis*
Lwin, S. M., Snowden, J. A., & Griffiths, C. E. M. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20517 · Cited by 46
Oncogenic senescence: a multi-functional perspective
Baker, D. J., Alimirah, F., van Deursen, J. M., Campisi, J., & Hildesheim, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15742 · Cited by 45
The Emerging View of Aging as a Reversible Epigenetic Process
López-León, M., & Goya, R. G. (2017) · Gerontology · doi:10.1159/000477209 · Cited by 45
de Lázaro, I., Yilmazer, A., Nam, Y., Qubisi, S., Razak, F. M. A., Degens, H., Cossu, G., & Kostarelos, K. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.014 · Cited by 44
MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming
Prieto, J., Seo, A. Y., León, M., Santacatterina, F., Torresano, L., Palomino‐Schätzlein, M., Giménez-Orenga, K., Vallet-Sánchez, A., Ponsoda, X., Pineda‐Lucena, A., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.018 · Cited by 44
Circadian clock and cancer: From a viewpoint of cellular differentiation
Tsuchiya, Y., Umemura, Y. M., & Yagita, K. (2020) · International Journal of Urology · doi:10.1111/iju.14231 · Cited by 44
Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology
Paine, P., Nguyen, A. T., & Ocampo, A. (2023) · Aging Cell · doi:10.1111/acel.14039 · Cited by 44
Senescent cells as a target for anti-aging interventions: From senolytics to immune therapies
Fu, T., & Zhou, Z. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0005 · Cited by 44
Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity
Tu, S., Zhang, M., Wood, C. G., & Pisters, L. L. (2021) · Cancers · doi:10.3390/cancers13164006 · Cited by 43
Cellular reprogramming for understanding and treating human disease
Kanherkar, R. R., Bhatia‐Dey, N., Makarev, E., & Csoka, A. B. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00067 · Cited by 43
Partial reprogramming strategy for intervertebral disc rejuvenation by activating energy switch
Cheng, F., Wang, C., Ji, Y., Yang, B., Shu, J., Shi, K., Wang, L., Wang, S., Zhang, Y., Huang, X., et al. (2022) · Aging Cell · doi:10.1111/acel.13577 · Cited by 42
Stem cell-based organ replacements—Airway and lung tissue engineering
Fishman, J. M., Lowdell, M. W., & Birchall, M. (2014) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2014.04.002 · Cited by 42
Cellular senescence in tissue repair: every cloud has a silver lining
Yun, M. H. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180081my · Cited by 41
Restoring aged stem cell functionality: Current progress and future directions
Spehar, K., Pan, A., & Beerman, I. (2020) · Stem Cells · doi:10.1002/stem.3234 · Cited by 41
Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche
Xu, L., Ramirez-Matias, J., Hauptschein, M., Sun, E., Lunger, J. C., Buckley, M. T., & Brunet, A. (2024) · Nature Aging · doi:10.1038/s43587-024-00594-3 · Cited by 41
Yang, C. M., Chiba, T., Brill, B., Delis, N., von Manstein, V., Vafaizadeh, V., Oellerich, T., & Groner, B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29606 · Cited by 41
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
DNA methylation and histone variants in aging and cancer
Mangelinck, A., & Mann, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.06.002 · Cited by 41
Stem cell transplantation in neurological diseases: improving effectiveness in animal models
Adami, R., Scesa, G., & Bottai, D. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00017 · Cited by 42
SOX2 expression diminishes with ageing in several tissues in mice and humans
Carrasco‐García, E., Moreno‐Cugnon, L., García, I., Borrás, C., Revuelta, M., Izeta, A., López‐Lluch, G., de Pancorbo, M. M., Vergara, I., Viña, J., et al. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.008 · Cited by 40
Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis
Marión, R. M., López de Silanes, I., Mosteiro, L., Gamache, B., Abad, M., Guerra, C., Megías, D., Serrano, M., & Blasco, M. A. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.001 · Cited by 39
Self-citationPotential Clinical Implications of Senotherapies for Cardiovascular Disease
Suda, M., Katsuumi, G., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0657 · Cited by 40
Kim, J., Kim, S., Lee, S., Jo, B., Oh, J. Y., Kwon, E., Kim, K.-T., Adpaikar, A. A., Kim, E., Jung, H.-S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi8454 · Cited by 39
Targeting senescent cells for the treatment of age-associated diseases
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae091 · Cited by 40
BMP4 regulation of human trophoblast development
Li, Y., & Parast, M. M. (2014) · The International Journal of Developmental Biology · doi:10.1387/ijdb.130341mp · Cited by 39
Rejuvenation of Mesenchymal Stem Cells to Ameliorate Skeletal Aging
Cheng, M., Yuan, W., Moshaverinia, A., & Yu, B. (2023) · Cells · doi:10.3390/cells12070998 · Cited by 39
Regenerative Cell Therapy for Corneal Endothelium
Bartáková, A., Kunzevitzky, N. J., & Goldberg, J. L. (2014) · Current Ophthalmology Reports · doi:10.1007/s40135-014-0043-7 · Cited by 38
Genetic and epigenetic alterations in aging and rejuvenation of human
Park, K., Jeon, M. C., Lee, D., Kim, J., & Im, S.-W. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100137 · Cited by 37
Conod, A., Silvano, M., & Altaba, A. R. I. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110490 · Cited by 37
Age reprogramming and epigenetic rejuvenation
Singh, P. B., & Newman, A. G. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0244-7 · Cited by 36
The molecular underpinnings of totipotency
Morgani, S. M., & Brickman, J. M. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0549 · Cited by 37
Smith, D. K., He, M., Zhang, C., & Zheng, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.006 · Cited by 37
Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues
Alle, Q., Le Borgne, E., Milhavet, O., & Lemaitre, J.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083990 · Cited by 35
p16High senescence restricts cellular plasticity during somatic cell reprogramming
Grigorash, B. B., van Essen, D., Liang, G., Grosse, L., Emelyanov, A., Kang, Z., Korablev, A. N., Kanzler, B., Molina, C., Lopez, E., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01214-9 · Cited by 35
In vivo reprogramming for tissue regeneration and organismal rejuvenation
Taguchi, J., & Yamada, Y. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.008 · Cited by 35
The RNA Polymerase II Factor RPAP1 Is Critical for Mediator-Driven Transcription and Cell Identity
Lynch, C. J., Bernad, R., Calvo, I., Pereira, S. N., Ruiz, S., Ibarz, N., Martínez‐Val, A., Graña‐Castro, O., Goméz-López, G., Andrés‐León, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.062 · Cited by 35
Self-citationSustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma
Karg, M. M., Lu, Y. R., Refaian, N., Cameron, J., Hoffmann, E., Hoppe, C., Shirahama, S., Shah, M., Krasniqi, D., Krishnan, A., et al. (2023) · Cellular Reprogramming · doi:10.1089/cell.2023.0074 · Cited by 34
Deciphering the roadmap of in vivo reprogramming toward pluripotency
Chondronasiou, D., Martínez de Villarreal, J., Melendez, E., Lynch, C. J., Pozo, N. D., Kovatcheva, M., Aguilera, M., Prats, N., Real, F. X., & Serrano, M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.09.009 · Cited by 34
Self-citationThe fate of cell reprogramming
Karagiannis, P., & Yamanaka, S. (2014) · Nature Methods · doi:10.1038/nmeth.3109 · Cited by 34
Vascular diseases await translation of blood vessels engineered from stem cells
Samuel, R., Duda, D. G., Fukumura, D., & Jain, R. K. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1805 · Cited by 35
Pereira, S. M., Ribeiro, R., & Logarinho, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040938 · Cited by 34
Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer
Menéndez, J. A., & Alarcón, T. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00049 · Cited by 34
Amphiregulin mediates non-cell-autonomous effect of senescence on reprogramming
von Joest, M., Chen, C., Douché, T., Chantrel, J., Chiche, A., Gianetto, Q. G., Matondo, M., & Li, H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111074 · Cited by 33
Agammaglobulinemia: causative mutations and their implications for novel therapies
Berglöf, A., Turunen, J. J., Gissberg, O., Bestas, B., Blomberg, K. E. M., & Smith, C. E. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.850030 · Cited by 33
In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases
Singovski, G., Bernal, C., Kuciak, M., Siegl‐Cachedenier, I., Conod, A., & Altaba, A. R. I. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv034 · Cited by 33
Epigenetic Clock and Circadian Rhythms in Stem Cell Aging and Rejuvenation
Samoilova, E. M., Викторович, Б. В., Ekusheva, E. V., Zhang, C., Troitskiy, A. V., & Baklaushev, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111050 · Cited by 32
Imprinting fidelity in mouse iPSCs depends on sex of donor cell and medium formulation
Arez, M., Eckersley-Maslin, M. A., Klobučar, T., Lopes, J. V. G., Krueger, F., Mupo, A., Raposo, A. C., Oxley, D., Mancino, S., Gendrel, A.-V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33013-5 · Cited by 32
Antón‐Fernández, A., Roldán-Lázaro, M., Vallés‐Saiz, L., Ávila, J., & Hernández, F. (2024) · Communications Biology · doi:10.1038/s42003-024-06328-w · Cited by 32
Potentials of Cellular Reprogramming as a Novel Strategy for Neuroregeneration
Fang, L., Wazan, L. E., Tan, C. L. H., Nguyen, T., Hung, S. S. C., Hewitt, A. W., & Wong, R. C. B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00460 · Cited by 31
A ride through the epigenetic landscape: aging reversal by reprogramming
Camillo, L. P. D. L., & Quinlan, R. B. A. (2021) · GeroScience · doi:10.1007/s11357-021-00358-6 · Cited by 32
Balistreri, C. R. (2018) · Mediators of Inflammation · doi:10.1155/2018/3705389 · Cited by 31
Cellular reprogramming and the rise of rejuvenation biotech
de Magalhães, J. P., & Ocampo, A. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.01.011 · Cited by 30
Bilineage embryo-like structure from EPS cells can produce live mice with tetraploid trophectoderm
Liu, K., Xu, X., Bai, D., Li, Y., Zhang, Y., Jia, Y., Guo, M., Han, X., Liu, Y., Sheng, Y., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac029 · Cited by 30
Strategies for in vivo reprogramming
Ofenbauer, A., & Tursun, B. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.06.002 · Cited by 30
Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer
Wang, L., Xiong, X., Yao, Z., Zhu, J., Lin, Y., Lin, W., Li, K., Xu, X., Guo, Y. Z., Chen, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.052 · Cited by 30
de Lázaro, I., Cossu, G., & Kostarelos, K. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707650 · Cited by 29
Gazdhar, A., Ravikumar, P., Pastor, J. V., Heller, M., Ye, J., Zhang, J., Moe, O. W., Geiser, T., & Hsia, C. C. W. (2017) · Stem Cells · doi:10.1002/stem.2752 · Cited by 29
Developmental programming of adult haematopoiesis system
Balistreri, C. R., Garagnani, P., Madonna, R., Vaiserman, A., & Melino, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100918 · Cited by 28
Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming
Shen, Y.-R., Zaballa, S., Bech, X., Sancho‐Balsells, A., Rodríguez-Navarro, I., Cifuentes-Díaz, C., Seyit-Bremer, G., Chun, S. H., Straub, T., Abante, J., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.013 · Cited by 28
Self-citationIn Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia
Seo, J. H., Lee, M.-Y., Yu, J. H., Kim, M., Song, M., Seo, C. H., Kim, S., & Cho, S. (2016) · Molecular Therapy · doi:10.1038/mt.2016.124 · Cited by 28
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Niklander, S. E., Lambert, D., & Hunter, K. D. (2021) · Cells · doi:10.3390/cells10123315 · Cited by 28
Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 28
Corbineau, S., Lassalle, B., Givelet, M., Souissi, I., Firlej, V., Roméo, P., Allemand, I., Riou, L., & Fouchet, P. (2016) · Oncotarget · doi:10.18632/oncotarget.14327 · Cited by 28
Histone modifiers: Dynamic regulators of the cutaneous transcriptome
Ghosh, K., O’Neil, K., & Capell, B. C. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.12.006 · Cited by 28
Pioneer Factors and Architectural Proteins Mediating Embryonic Expression Signatures in Cancer
Dobersch, S., Rubio, K., & Barreto, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.008 · Cited by 28
A multiscale model of epigenetic heterogeneity-driven cell fate decision-making
Folguera-Blasco, N., Perez‐Carrasco, R., Cuyàs, E., Menéndez, J. A., & Alarcón, T. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006592 · Cited by 28
Aging: A cell source limiting factor in tissue engineering
Khorraminejad‐Shirazi, M., Dorvash, M., Estedlal, A., Hoveidaei, A. H., Mazloomrezaei, M., & Mosaddeghi, P. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i10.787 · Cited by 28
Epigenetic regulation leading to induced pluripotency drives cancer development in vivo
Ohnishi, K., Semi, K., & Yamada, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.020 · Cited by 27
Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer
Prieto, J., & Torres, J. (2017) · Stem Cells International · doi:10.1155/2017/8073721 · Cited by 27
Gómez‐Redondo, I., Ramos‐Ibeas, P., Pericuesta, E., Fernández‐González, R., Laguna‐Barraza, R., & Gutiérrez‐Adán, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114115 · Cited by 27
Pensotti, A., Bizzarri, M., & Bertolaso, M. (2024) · Oncology Reports · doi:10.3892/or.2024.8707 · Cited by 27
Hypoxia Induces Pluripotency in Primordial Germ Cells by HIF1α Stabilization and Oct4 Deregulation
López-Iglesias, P., Alcaina, Y., Tàpia, N., Sabour, D., Araúzo-Bravo, M. J., de la Maza, D. S., Berra, E., Núñez-O’Mara, A., Nistal, M., Ortega, S., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5871 · Cited by 27
Self-citationRegenerative medicine: Transdifferentiation in vivo
Fu, L., Zhu, X., Yi, F., Liu, G., & Belmonte, J. C. I. (2013) · Cell Research · doi:10.1038/cr.2013.165 · Cited by 27
Mature cystic teratomas arise from meiotic oocytes, but not from pre‐meiotic oogonia
Kaku, H., Usui, H., Qu, J., & Shozu, M. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22339 · Cited by 27
Metadata
- Authors
- Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., Manzanares, M., Ortega, S., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Corresponding author
- Serrano, Manuel
- Venue
- Nature
- Published
- 2013-09-11
- Volume
- 502
- Issue
- 7471
- Pages
- 340-345
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051454588
- Cited by
- 547
- References
- 46
- Citations by year
- 2026: 30 · 2025: 37 · 2024: 41 · 2023: 46 · 2022: 51 · 2021: 46 · 2020: 47 · 2019: 35 · 2018: 38 · 2017: 47 · 2016: 26 · 2015: 38 · 2014: 54 · 2013: 11
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- CEU Repositorio Institucional (Fundación Universitaria San Pablo CEU) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- in vivo reprogramming, induced pluripotent stem cells, teratoma, totipotency, Yamanaka factors, Oct4, SOX2, KLF4, c-Myc, Nanog, trophectoderm, embryonic stem cells, regenerative medicine
- MeSH terms
- Kruppel-Like Factor 4, Animals, Blood Cells, Cell Separation, Cells, Cultured, Ectoderm, Female, Fibroblasts, Intestines, Kidney, Male, Mice, Inbred C57BL, Organ Specificity, Pancreas, Stomach, Teratoma, Trophoblasts, Proto-Oncogene Proteins c-myc, Gene Expression Profiling, Totipotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, Embryonic Stem Cells, Cell Dedifferentiation, SOXB1 Transcription Factors, Induced Pluripotent Stem Cells, Embryoid Bodies, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.